Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.

Autor: Rosano, Giuseppe1 (AUTHOR) giuseppe.rosano@gmail.com, Ponikowski, Piotr2,3 (AUTHOR), Vitale, Cristiana1 (AUTHOR), Anker, Stefan D.4 (AUTHOR), Butler, Javed5,6 (AUTHOR), Fabien, Vincent7 (AUTHOR), Filippatos, Gerasimos8 (AUTHOR), Kirwan, Bridget-Anne9,10 (AUTHOR), Macdougall, Iain C.11 (AUTHOR), Metra, Marco12 (AUTHOR), Ruschitzka, Frank13 (AUTHOR), Kumpeson, Vasuki7 (AUTHOR), Goehring, Udo-Michael7 (AUTHOR), van der Meer, Peter14 (AUTHOR), Jankowska, Ewa A.2,3 (AUTHOR)
Zdroj: Cardiovascular Diabetology. 8/17/2023, Vol. 22 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje